BR100 Increased By (0.58%)
BR30 Increased By (0.59%)
KSE100 Increased By (0.35%)
KSE30 Increased By (0.26%)
BECO 6.06 Increased By ▲ 0.03 (0.5%)
BML 57.96 Increased By ▲ 5.21 (9.88%)
BOP 34.19 Decreased By ▼ -0.06 (-0.18%)
CNERGY 8.25 Increased By ▲ 0.09 (1.1%)
DCL 12.23 Decreased By ▼ -0.11 (-0.89%)
FCCL 54.26 Increased By ▲ 0.37 (0.69%)
FCSC 5.23 Increased By ▲ 0.01 (0.19%)
FFL 18.13 Increased By ▲ 0.10 (0.55%)
FNEL 1.31 Increased By ▲ 0.01 (0.77%)
HUMNL 11.22 Increased By ▲ 0.22 (2%)
KEL 8.16 Increased By ▲ 0.05 (0.62%)
KOSM 5.46 Increased By ▲ 0.08 (1.49%)
MLCF 89.21 Increased By ▲ 1.16 (1.32%)
NBP 186.87 Increased By ▲ 0.39 (0.21%)
PACE 10.72 No Change ▼ 0.00 (0%)
PAEL 40.40 Increased By ▲ 0.46 (1.15%)
PIAHCLA 26.33 Increased By ▲ 0.16 (0.61%)
PIBTL 17.44 Increased By ▲ 0.12 (0.69%)
PPL 233.30 Increased By ▲ 0.52 (0.22%)
PRL 34.90 Decreased By ▼ -0.05 (-0.14%)
PTC 67.18 Decreased By ▼ -0.38 (-0.56%)
SEARL 91.21 Increased By ▲ 0.28 (0.31%)
SSGC 27.10 Decreased By ▼ -0.07 (-0.26%)
TELE 8.58 Increased By ▲ 0.01 (0.12%)
THCCL 64.86 Increased By ▲ 4.73 (7.87%)
TPLP 9.10 Increased By ▲ 0.34 (3.88%)
TREET 24.79 Increased By ▲ 0.25 (1.02%)
TRG 73.30 Increased By ▲ 1.55 (2.16%)
WAVES 10.62 Increased By ▲ 0.64 (6.41%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)

ISLAMABAD: Following the response to a letter from Transparency International Pakistan (TIP), the Prime Minister (PM) of Pakistan Shehbaz Sharif has taken serious action to combat the proliferation of fake and substandard medicines in the country.

The Prime Minister has appointed Zeeshan Nazir Bajwa as the new Drug Controller/ Director. Prior to this appointment, Bajwa served as the Deputy Director General at the Drug Regulatory Authority of Pakistan (DRAP).

The appointment was made based on the recommendations of the Central Selection Board and with the approval of the Prime Minister, according to an official notification issued by the Ministry of National Health Services, Regulations and Coordination.

The notification states that Bajwa’s appointment as Drug Controller/ Director (BS-20) is effective immediately. He will be working under DRAP, which operates under the Ministry of National Health Services, Regulations and Coordination. This move signifies the government’s commitment to addressing concerns raised by Transparency International and to ensuring the availability of quality and safe medicines for the citizens of Pakistan.

Copyright Business Recorder, 2025

Comments

Comments are closed for this article.